WallStSmart
CNTN

Canton Strategic Holdings, Inc.

NASDAQ: CNTN · HEALTHCARE · BIOTECHNOLOGY

$3.51
-15.51% today

Updated 2026-06-02

Market cap
$187.08M
P/E ratio
P/S ratio
EPS (TTM)
$-0.36
Dividend yield
52W range
$1 – $9
Volume
0.6M

Canton Strategic Holdings, Inc. (CNTN) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2019202020212022202320242025
Revenue$0.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)
Cost of revenue
Gross profit
Gross margin
R&D$368732.00$847272.00$1.84M$2.28M$3.56M$6.39M$3.07M
SG&A$1.37M$4.60M$5.90M$6.04M$17.03M
Operating income$-994539.00$-1.52M$-3.21M$-6.88M$-9.46M$-12.43M$-20.11M
Operating margin
EBITDA$-1.45M$-2.17M$-1.38M$-6.65M$-9.15M$-12.43M$-20.11M
EBITDA margin
EBIT$-6.88M$-9.30M$-12.21M
Interest expense$75074.00$246534.00$831277.00$1.59M$16505.00$13684.00$28345.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-1.53M$-2.42M$-2.21M$-8.47M$-9.32M$-12.20M$-35.92M
Net income growth (YoY)-58.5%+8.7%-284.0%-10.0%-30.9%-194.5%
Profit margin

Frequently asked questions

How much free cash flow does CNTN generate?

CNTN produced $-93.70M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is CNTN's balance sheet healthy?

CNTN holds $17.03M in cash and equivalents against — in long-term debt, on $397.93M of shareholder equity. That debt is best read against the cash flow the business throws off each year.